AMWL
American Well Corporation
AMWL lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
AMWL Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Under pressure | |
| Unavailable |
AMWL's revenue, profitability and cash flow are currently under pressure. There isn't enough data to rate its balance sheet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
AMWL PE Valuation
AMWL has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
AMWL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect AMWL's losses to shrink, with revenue holding steady. However, they disagree widely on these estimates.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
AMWL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.45 | +$3.63 |
| Q2 2026 | -$4.78 | +$3.17 |
| Q1 2026 | -$5.43 | +$4.64 |
| Q4 2025 | -$5.96 | +$7.92 |
| Q3 2025 | -$7.08 | +$7.15 |
| Q2 2025 | -$7.95 | +$13.01 |
| Q1 2025 | -$10.07 | +$14.13 |
| Q4 2024 | -$13.88 | +$33.72 |
AMWL has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
AMWL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $49M | -13% |
| Q2 2026 | $52M | -27% |
| Q1 2026 | $54.9M | -18% |
| Q4 2025 | $55.3M | -22% |
| Q3 2025 | $56.3M | -7.8% |
| Q2 2025 | $70.9M | +13% |
| Q1 2025 | $66.8M | +12% |
| Q4 2024 | $71M | +0.5% |
AMWL's revenue has slid since its 2022 peak: $49M last quarter, down 13% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -24% | +28 points |
| Q2 2026 | -18% | +10 points |
| Q1 2026 | -32% | +14 points |
| Q4 2025 | -45% | +15 points |
| Q3 2025 | -52% | +26 points |
| Q2 2025 | -29% | +55 points |
| Q1 2025 | -46% | +81 points |
| Q4 2024 | -60% | +20 points |
AMWL's operating margin was −24% last quarter, up 28 points from the same quarter a year ago, near the top of its range since 2019.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over AMWL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over AMWL on profitability, with a higher operating margin.
AMWL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$11.7M | +$7.1M |
| Q2 2026 | $10.7M | +$15.4M |
| Q1 2026 | -$988K | +$24.1M |
| Q4 2025 | -$17.4M | -$3.9M |
| Q3 2025 | -$18.8M | +$13.6M |
| Q2 2025 | -$4.7M | +$17.1M |
| Q1 2025 | -$25.1M | +$34.7M |
| Q4 2024 | -$13.4M | +$28.2M |
AMWL has burned cash in almost every quarter: −$19M over the past year, against −$62M the year before.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over AMWL on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMWL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.8% | +299K shares |
| 1 year | +5.2% | +845K shares |
| 3 years | +19% | +2.8M shares |
| 5 years | +33% | +4.2M shares |
| Available history | +772% | +15.1M shares |
AMWL has 17M diluted shares, up 5.2% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1,000 |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $1,000 |
| Q3 2025 | $1,000 |
| Q2 2025 | $1,000 |
| Q1 2025 | $1,000 |
| Q4 2024 | $2,000 |
AMWL has spent almost nothing on buybacks in the past year.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over AMWL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
AMWL Net Leverage
AMWL's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
AMWL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.2 | Neutral |
| Stochastic | 37.6 | Neutral |
AMWL's weekly RSI is 54 (neutral) and its Stochastic is 38 (neutral).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
AMWL PE vs Healthcare Sector
AMWL has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
AMWL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $12.6 | 4.1% below |
| 20 week MA | $12.2 | 1.4% below |
| 50 week MA | $8.53 | 41% above |
| 100 week MA | $7.98 | 51% above |
| 200 week MA | $17.1 | 30% below |
AMWL has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
AMWL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $460.4 | $595.0 | +29% |
| 2021 | $595.0 | $128.6 | -78% |
| 2022 | $128.6 | $61.6 | -52% |
| 2023 | $61.6 | $29.8 | -52% |
| 2024 | $29.8 | $7.80 | -74% |
| 2025 | $7.80 | $4.55 | -42% |
| 2026 YTD | $4.55 | $12.0 | +164% |
AMWL has the edge over HIMS on returns for 2026, with the stronger performance.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.